Literature DB >> 24160854

Prevalence of hearing loss in patients with late-onset Pompe disease: Audiological and otological consequences.

F Hanisch1, T Rahne, S K Plontke.   

Abstract

OBJECTIVE: The metabolic disorder Pompe disease mainly affects the skeletal muscle in adults. The hearing impairment due to stapedius muscle involvement in adult patients is not known.
DESIGN: The frequency, severity, and type of hearing impairment was characterized prospectively using pure-tone audiometry, tympanometry, stapedial reflexes, otoacoustic emissions, and brainstem-evoked response audiometry in adult patients on enzyme replacement therapy for genetically confirmed Pompe disease. STUDY SAMPLE: 11 adult patients (median age: 47 years, range: 22-71).
RESULTS: Four patients complained about subjective hearing disturbances. Using World Health Organization definition of hearing impairment, abnormal hearing thresholds resulting in mild hearing loss were found in 36% of patients. Compared to normative data (ISO 7029), the hearing threshold was below the median in all but three ears. Stapedial reflexes could not be elicited ipsilateral in 18% and contralateral in 36%. Auditory brainstem responses showed no retrocochlear pathology.
CONCLUSIONS: The prevalence of hearing loss slightly exceeded the normative data of the general population. Consistent with previous studies the hearing impairment was usually mild. The percentage of pathological stapedial reflexes exceeded that of matched control subjects and suggests a selective involvement of the stapedius muscle, potentially as a sequela of Pompe disease.

Entities:  

Mesh:

Year:  2013        PMID: 24160854     DOI: 10.3109/14992027.2013.840932

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  5 in total

1.  Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.

Authors:  Federica Montagnese; E Barca; O Musumeci; S Mondello; A Migliorato; A Ciranni; C Rodolico; P De Filippi; C Danesino; A Toscano
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

2.  Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation.

Authors:  Xiao Liu; Zhaoxia Wang; Weina Jin; He Lv; Wei Zhang; Chengli Que; Yu Huang; Yun Yuan
Journal:  BMC Med Genet       Date:  2014-12-20       Impact factor: 2.103

3.  Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group.

Authors:  Fatma Al Jasmi; Mohammed Al Jumah; Fatimah Alqarni; Nouriya Al-Sanna'a; Fawziah Al-Sharif; Saeed Bohlega; Edward J Cupler; Waseem Fathalla; Mohamed A Hamdan; Nawal Makhseed; Shahriar Nafissi; Yalda Nilipour; Laila Selim; Nuri Shembesh; Rawda Sunbul; Seyed Hassan Tonekaboni
Journal:  BMC Neurol       Date:  2015-10-15       Impact factor: 2.474

4.  Early detection of sensorineural hearing loss in Muckle-Wells-syndrome.

Authors:  Jasmin B Kuemmerle-Deschner; Assen Koitschev; Pascal N Tyrrell; Stefan K Plontke; Norbert Deschner; Sandra Hansmann; Katharina Ummenhofer; Peter Lohse; Christiane Koitschev; Susanne M Benseler
Journal:  Pediatr Rheumatol Online J       Date:  2015-11-04       Impact factor: 3.054

5.  Can stapedius reflex testing objectively measure muscle function in Pompe patients?

Authors:  Max J Hilz; Ulrich Hoppe; Sebastian Moeller; Ruihao Wang; Julia Koehn
Journal:  Clin Case Rep       Date:  2015-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.